P

Panagene Inc
KOSDAQ:046210

Watchlist Manager
Panagene Inc
KOSDAQ:046210
Watchlist
Price: 1 790 KRW -4.18%
Market Cap: ₩80.8B

Net Margin

11.8%
Current
Improving
by 27.8%
vs 3-y average of -16%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
11.8%
=
Net Income
₩1.7B
/
Revenue
₩14.3B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
11.8%
=
Net Income
₩1.7B
/
Revenue
₩14.3B

Peer Comparison

Country Company Market Cap Net
Margin
KR
Panagene Inc
KOSDAQ:046210
80.8B KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
393.1B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
185.9B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
172.7B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.7B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.5B USD
Loading...
AU
CSL Ltd
ASX:CSL
88.4B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.4B EUR
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...

Market Distribution

Higher than 85% of companies in Korea
Percentile
85th
Based on 2 632 companies
85th percentile
11.8%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

Panagene Inc
Glance View

Market Cap
80.8B KRW
Industry
Biotechnology

PANAGENE Inc. engages in the molecular diagnostics business. The company is headquartered in Daejeon, Daejeon and currently employs 71 full-time employees. The company went IPO on 2000-08-16. The firm develops selective deoxyribonucleic acid (DNA) amplification technology and detection technology which used in the drug susceptibity testing, single nucleotide sequence variation inspection, infectious diseases hospital inspection and other DNA relates diseases inspection. The Company’s customs mainly include DAKO, AdvanDx, Abbott, LSI Medience Corporation and others.

Panagene Inc Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
11.8%
=
Net Income
₩1.7B
/
Revenue
₩14.3B
What is Panagene Inc's current Net Margin?

The current Net Margin for Panagene Inc is 11.8%, which is above its 3-year median of -16%.

How has Net Margin changed over time?

Over the last 3 years, Panagene Inc’s Net Margin has decreased from 18.2% to 11.8%. During this period, it reached a low of -73.4% on Jun 30, 2024 and a high of 18.2% on Sep 30, 2022.

Back to Top